These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5514720)

  • 21. Value of electrical pacing and beta adrenergic blockers in the prevention of fatal ventricular arrhythmias.
    Mansour KA; Zakaryia MS; Hatcher CR
    Am Surg; 1971 Sep; 37(9):533-6. PubMed ID: 4399445
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electrophysiological changes in different layers of the ventricular wall of a dog caused by 60-minute coronary artery ligation and reperfusion. I. Studies of extracellular potentials in situ].
    Beresewicz A; Sedek G
    Kardiol Pol; 1981; 24(3):221-35. PubMed ID: 7019537
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ventricular fibrillation due to sudden restoration of circulation in the coronary vessels (experimental data)].
    Arnulf G
    Bull Acad Natl Med; 1971 Nov; 155(30):789-96. PubMed ID: 4948400
    [No Abstract]   [Full Text] [Related]  

  • 24. Preservation of myocardial viability by diastolic augmentation after ligation of the coronary artery in dogs.
    Goldfarb D; Friesinger GC; Conti CR; Brown BG; Gott VL
    Surgery; 1968 Feb; 63(2):320-7. PubMed ID: 5638178
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of myocardial revascularization on ventricular fibrillation thresholds in dogs.
    Kass TG; Symes JF; Chiu CJ; Blundell PE
    Can J Surg; 1974 Mar; 17(2):97-101. PubMed ID: 4817698
    [No Abstract]   [Full Text] [Related]  

  • 26. Early and delayed afterdepolarizations associated with cesium chloride-induced arrhythmias in the dog.
    Patterson E; Szabo B; Scherlag BJ; Lazzara R
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):323-31. PubMed ID: 1689430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
    Málek P; Vrána M; Kolc J; Netusil M; Blazek Z
    Int J Clin Pharmacol; 1974 Dec; 10(4):273-82. PubMed ID: 4140846
    [No Abstract]   [Full Text] [Related]  

  • 28. Actions of prostaglandins I2 and E2 on coronary occlusion-induced arrhythmias in the rat.
    Au TL; Collins GA; Harvie CJ; Walker MJ
    Adv Prostaglandin Thromboxane Res; 1980; 7():647-9. PubMed ID: 6989191
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacologic prevention of fibrillation in acute ischemia of the heart and the dynamics of electrolytes].
    Popova NK; Ivashkevich EI
    Biull Eksp Biol Med; 1965 May; 59(5):64-7. PubMed ID: 5880812
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular recording from the in situ working dog heart in physiological conditions and during acute ischemia and fibrillation.
    Czarnecka M; Lewartowski B; Prokopczuk A
    Acta Physiol Pol; 1973; 24(2):331-7. PubMed ID: 4711432
    [No Abstract]   [Full Text] [Related]  

  • 32. [Survival rate after acute experimental coronary occlusion as related to the spontaneous collateral vessels in hearts].
    Meesmann W; Schulz FW; Schley G; Adolphsen P
    Z Gesamte Exp Med Einschl Exp Chir; 1970; 153(3):246-64. PubMed ID: 5526834
    [No Abstract]   [Full Text] [Related]  

  • 33. A method for producing controllable coronary embolization.
    Sekiguchi S; Soroff HS; Birtwell WC; Kahn PC
    J Thorac Cardiovasc Surg; 1969 Apr; 57(4):585-96. PubMed ID: 5774637
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ventricular fibrillation during reestablishment of coronary artery circulation (clamp release fibrillation)].
    Arnulf G; Martin C
    Arch Mal Coeur Vaiss; 1973 Jul; 66(7):869-76. PubMed ID: 4200947
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of chloroform and thiobarbiturate cardiac sensitization to catecholamines in dogs.
    Claborn LD; Szabuniewicz M
    Am J Vet Res; 1973 Jun; 34(6):801-4. PubMed ID: 4707565
    [No Abstract]   [Full Text] [Related]  

  • 36. Electrophysiology underlying ventricular arrhythmias due to coronary ligation.
    Scherlag BJ; Helfant RH; Haft JI; Damato AN
    Am J Physiol; 1970 Dec; 219(6):1665-71. PubMed ID: 5312495
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of ventricular fibrillation after ligation of circumflex artery.
    Hiatt N; Rabinowitz B; Yamakawa T; Miller A; Sheinkopf JA; Warner NE
    J Thorac Cardiovasc Surg; 1973 Aug; 66(2):283-6. PubMed ID: 4720980
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes of rhythm after ligation of the arteries of the sinoatrial node and simultaneous sectioning of the internodal tracts in the dog heart].
    Pagan V; Losi C; Cigaina V; Zaccaria F; Zotti EF
    Chir Patol Sper; 1980 Apr; 28(2):87-98. PubMed ID: 7307692
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation.
    Billman GE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):407-16. PubMed ID: 8331569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoprostenol (PGI2) reduces the incidence of post-reperfusion ventricular fibrillation in the dog.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Serradimigni A
    Cardiologia; 1985 Feb; 30(2):91-7. PubMed ID: 3905005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.